Literature DB >> 20890124

p62/SQSTM1 is required for Parkin-induced mitochondrial clustering but not mitophagy; VDAC1 is dispensable for both.

Derek Narendra1, Lesley A Kane, David N Hauser, Ian M Fearnley, Richard J Youle.   

Abstract

Mitochondria sustain damage with aging, and the resulting mitochondrial dysfunction has been implicated in a number of diseases including Parkinson disease. We recently demonstrated that the E3 ubiquitin ligase Parkin, which is linked to recessive forms of parkinsonism, causes a dramatic increase in mitophagy and a change in mitochondrial distribution, following its translocation from the cytosol to mitochondria. Investigating how Parkin induces these changes may offer insight into the mechanisms that lead to the sequestration and elimination of damaged mitochondria. We report that following Parkin’s translocation from the cytosol to mitochondria, Parkin (but not a pathogenic mutant) promotes the K63-linked polyubiquitination of mitochondrial substrate(s) and recruits the ubiquitin- and LC3-binding protein, p62/SQSTM1, to mitochondria. After its recruitment, p62/SQSTM1 mediates the aggregation of dysfunctional mitochondria through polymerization via its PB1 domain, in a manner analogous to its aggregation of polyubiquitinated proteins. Surprisingly and in contrast to what has been recently reported for ubiquitin-induced pexophagy and xenophagy, p62 appears to be dispensable for mitophagy. Similarly, mitochondrial-anchored ubiquitin is sufficient to recruit p62 and promote mitochondrial clustering, but does not promote mitophagy. Although VDAC1 (but not VDAC2) is ubiquitinated following mitochondrial depolarization, we find VDAC1 cannot fully account for the mitochondrial K63-linked ubiquitin immunoreactivity observed following depolarization, as it is also observed in VDAC1/3-/- mouse embryonic fibroblasts. Additionally, we find VDAC1 and VDAC3 are dispensable for the recruitment of p62, mitochondrial clustering and mitophagy. These results demonstrate that mitochondria are aggregated by p62, following its recruitment by Parkin in a VDAC1-independent manner. They also suggest that proteins other than p62 are likely required for mitophagy downstream of Parkin substrates other than VDAC1.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20890124      PMCID: PMC3359490          DOI: 10.4161/auto.6.8.13426

Source DB:  PubMed          Journal:  Autophagy        ISSN: 1554-8627            Impact factor:   16.016


  50 in total

1.  Short-lived green fluorescent proteins for quantifying ubiquitin/proteasome-dependent proteolysis in living cells.

Authors:  N P Dantuma; K Lindsten; R Glas; M Jellne; M G Masucci
Journal:  Nat Biotechnol       Date:  2000-05       Impact factor: 54.908

2.  Aggresomes formed by alpha-synuclein and synphilin-1 are cytoprotective.

Authors:  Mikiei Tanaka; Yong Man Kim; Gwang Lee; Eunsung Junn; Takeshi Iwatsubo; M Maral Mouradian
Journal:  J Biol Chem       Date:  2003-11-19       Impact factor: 5.157

3.  The deacetylase HDAC6 regulates aggresome formation and cell viability in response to misfolded protein stress.

Authors:  Yoshiharu Kawaguchi; Jeffrey J Kovacs; Adam McLaurin; Jeffery M Vance; Akihiro Ito; Tso Pang Yao
Journal:  Cell       Date:  2003-12-12       Impact factor: 41.582

4.  Ubiquitin-binding protein p62 is present in neuronal and glial inclusions in human tauopathies and synucleinopathies.

Authors:  E Kuusisto; A Salminen; I Alafuzoff
Journal:  Neuroreport       Date:  2001-07-20       Impact factor: 1.837

5.  Inclusion body formation reduces levels of mutant huntingtin and the risk of neuronal death.

Authors:  Montserrat Arrasate; Siddhartha Mitra; Erik S Schweitzer; Mark R Segal; Steven Finkbeiner
Journal:  Nature       Date:  2004-10-14       Impact factor: 49.962

6.  Ubiquitin chain editing revealed by polyubiquitin linkage-specific antibodies.

Authors:  Kim Newton; Marissa L Matsumoto; Ingrid E Wertz; Donald S Kirkpatrick; Jennie R Lill; Jenille Tan; Debra Dugger; Nathaniel Gordon; Sachdev S Sidhu; Frederic A Fellouse; Laszlo Komuves; Dorothy M French; Ronald E Ferrando; Cynthia Lam; Deanne Compaan; Christine Yu; Ivan Bosanac; Sarah G Hymowitz; Robert F Kelley; Vishva M Dixit
Journal:  Cell       Date:  2008-08-22       Impact factor: 41.582

7.  Studies on human porin. VI. Production and characterization of eight monoclonal mouse antibodies against the human VDAC "Porin 31HL" and their application for histotopological studies in human skeletal muscle.

Authors:  D Babel; G Walter; H Götz; F P Thinnes; L Jürgens; U König; N Hilschmann
Journal:  Biol Chem Hoppe Seyler       Date:  1991-12

8.  p62 Is a common component of cytoplasmic inclusions in protein aggregation diseases.

Authors:  Kurt Zatloukal; Cornelia Stumptner; Andrea Fuchsbichler; Hans Heid; Martina Schnoelzer; Lukas Kenner; Reinhold Kleinert; Marco Prinz; Adriano Aguzzi; Helmut Denk
Journal:  Am J Pathol       Date:  2002-01       Impact factor: 4.307

9.  Mitochondrial pathology and apoptotic muscle degeneration in Drosophila parkin mutants.

Authors:  Jessica C Greene; Alexander J Whitworth; Isabella Kuo; Laurie A Andrews; Mel B Feany; Leo J Pallanck
Journal:  Proc Natl Acad Sci U S A       Date:  2003-03-17       Impact factor: 11.205

10.  Parkin is recruited selectively to impaired mitochondria and promotes their autophagy.

Authors:  Derek Narendra; Atsushi Tanaka; Der-Fen Suen; Richard J Youle
Journal:  J Cell Biol       Date:  2008-11-24       Impact factor: 10.539

View more
  336 in total

Review 1.  The interplay of neuronal mitochondrial dynamics and bioenergetics: implications for Parkinson's disease.

Authors:  Victor S Van Laar; Sarah B Berman
Journal:  Neurobiol Dis       Date:  2012-06-02       Impact factor: 5.996

Review 2.  Regulation of autophagy by protein post-translational modification.

Authors:  Willayat Yousuf Wani; Michaël Boyer-Guittaut; Matthew Dodson; John Chatham; Victor Darley-Usmar; Jianhua Zhang
Journal:  Lab Invest       Date:  2014-11-03       Impact factor: 5.662

Review 3.  Mitochondrial dynamics and mitophagy in Parkinson's disease: disordered cellular power plant becomes a big deal in a major movement disorder.

Authors:  Yuzuru Imai; Bingwei Lu
Journal:  Curr Opin Neurobiol       Date:  2011-11-01       Impact factor: 6.627

4.  PINK1- and Parkin-mediated mitophagy at a glance.

Authors:  Seok Min Jin; Richard J Youle
Journal:  J Cell Sci       Date:  2012-02-15       Impact factor: 5.285

Review 5.  Mitochondrial dysfunction in Parkinson's disease: molecular mechanisms and pathophysiological consequences.

Authors:  Nicole Exner; Anne Kathrin Lutz; Christian Haass; Konstanze F Winklhofer
Journal:  EMBO J       Date:  2012-06-26       Impact factor: 11.598

Review 6.  Mechanisms of selective autophagy and mitophagy: Implications for neurodegenerative diseases.

Authors:  Charleen T Chu
Journal:  Neurobiol Dis       Date:  2018-07-17       Impact factor: 5.996

7.  p62/SQSTM1 Cooperates with Hyperactive mTORC1 to Regulate Glutathione Production, Maintain Mitochondrial Integrity, and Promote Tumorigenesis.

Authors:  Hilaire C Lam; Christian V Baglini; Alicia Llorente Lope; Andrey A Parkhitko; Heng-Jia Liu; Nicola Alesi; Izabela A Malinowska; Darius Ebrahimi-Fakhari; Afshin Saffari; Jane J Yu; Ana Pereira; Damir Khabibullin; Barbara Ogorek; Julie Nijmeh; Taylor Kavanagh; Adam Handen; Stephen Y Chan; John M Asara; William M Oldham; Maria T Diaz-Meco; Jorge Moscat; Mustafa Sahin; Carmen Priolo; Elizabeth P Henske
Journal:  Cancer Res       Date:  2017-05-16       Impact factor: 12.701

8.  SirT3 regulates the mitochondrial unfolded protein response.

Authors:  Luena Papa; Doris Germain
Journal:  Mol Cell Biol       Date:  2013-12-09       Impact factor: 4.272

Review 9.  Posttranslational modification and quality control.

Authors:  Xuejun Wang; J Scott Pattison; Huabo Su
Journal:  Circ Res       Date:  2013-01-18       Impact factor: 17.367

Review 10.  Integration of cellular bioenergetics with mitochondrial quality control and autophagy.

Authors:  Bradford G Hill; Gloria A Benavides; Jack R Lancaster; Scott Ballinger; Lou Dell'Italia; Zhang Jianhua; Victor M Darley-Usmar
Journal:  Biol Chem       Date:  2012-12       Impact factor: 3.915

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.